2.35 (-2.89%)

T-O: 0.0 (08:59:00)
Last updated: 16:16

Fundamental   5.0  
Technical   2.5  
Total Score   7.5  

 Insti+   MT Sell- 


iSaham Fundamental Trend

FCON: 0.64 | Sharpe Ratio: 0.02 | LTS: 6.45

Quarter Reports

Trailing Dividend

Financial Ratios

EPS 20.99 sen
Trailing PE (Sector Median: 21.4) 11.1
PEG -3.54
Altman Z 1.9
Beaver 0.101
Current Ratio 3.3
Debt-Equity (DE) Ratio 0.41
FCF Yield 3.6 %
Dividend Per Share (DPS) 8.0 sen
Revenue QoQ -2.69 %
Revenue YoY 2.01 %
Profit QoQ 84.9 %
Profit YoY 19.86 %
NTA QoQ 5.75 %
Profit Margin (Sector Median: 5.0) 9.79 %
ROE 8.6 %
ROIC 8.0 %
Dividend Yield (DY) 3.4 %

Fair Value

iSaham Fair Value: 1.8

Discounted Cash Flow (DCF)5.0% Growth 1.8
Discounted Cash Flow (DCF)4.8% Growth 1.21
Relative Valuation 4.55
Graham Formula 1.59
Graham Number 3.42
Net Tangible Asset (NTA) 2.39

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 38.1
Expected Revenue (M) 389.14
Expected Growth (%) 11.0



Market Cap: 324 M.

Number of Shares: 138 M.

Float: 32.39%.

Stock highly correlated with

3A (100%)

ACOSTEC (100%)

AEM (100%)

AEONCR (100%)

Manipulation Indicator: Hard to manipulate.

Y.S.P Southeast Asia Holding Berhad, an investment holding company, is engaged in the manufacture, import, export, and trading of pharmaceutical products. It primarily offers pharmaceutical products, veterinary products, pharmaceutical fine chemicals, herbal products, over-the-counter products, and aquatic products. The company offers its products in various formats, such as gels, capsules, tablets, suppositories, creams, syrups, suspensions, and powder dosage forms. It has operations primarily in Malaysia, the Philippines, Myanmar, Singapore, Vietnam, Cambodia, and Indonesia. The company was founded in 1987 and is headquartered in Kuala Lumpur, Malaysia. Y.S.P Southeast Asia Holding Berhad is a subsidiary of YSP SEA Investment Co., Ltd.

Sectors: Consumer Products, Healthcare, Pharmaceuticals

Code: 7178

Website: http://www.yspsah.com/

Related Links: Bursa | Annual Report | Announcement

Top Shareholdings

Updated on 4-May-2020

Shareholder Value (M)
YSP International Company Limited 123.06
Dato' Dr. Lee Fang Hsin 34.25
Employees Provident Fund Board 12.26
Tan Kong Han 7.85
Amal Pintas Sdn Bhd 5.6
PB Islamic Smallcap Fund 4.88
Lee Ling-Chin 4.61
Dr. Lee Fang Chuan @ Lee Fang Chen 4.28
Credit Suisse 4.09
Dr. Lee Fang-Yu 3.4
Datuk Dr. Anis Bin Ahmad 3.06
Dr. Lee Fang-Jen 2.85
Yan Kai Yin 2.83
Tu Shu Yao 2.81
Leong Foong Fin 2.78
Datuk Koay Soon Eng 2.71
Liao, Miao-Yi 2.65
Lim Khuan Eng 2.56
Wong Ah Chiew 2.42
Tien Te Lee Biomedical Foundation 2.1
Wong Yee Hui 1.63
Lin, Chi-Jui 1.5
Chee Sai Mun 1.26
Lee, Ling-Fen 1.22
Lai, Chen-Chun 1.07
Andrew Lim Cheong Seng 1.06
Ting Chin Liu 1.02